Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute
- 1 February 2017
- journal article
- review article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 15 (2), 166-174
- https://doi.org/10.1016/j.cgh.2016.10.024
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infectionThe Lancet Infectious Diseases, 2013
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitisGut, 2013
- Current strategies for management of initial Clostridium difficile infectionJournal of Hospital Medicine, 2012
- Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2012
- Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent InfectionsClinical Infectious Diseases, 2011
- Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficilePLOS ONE, 2010
- Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile InfectionDigestive Diseases and Sciences, 2009
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesProceedings of the National Academy of Sciences of the United States of America, 2007
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaThe New England Journal of Medicine, 1978